Weight Loss after Roux-en-Y Gastric Bypass in Obese Patients Heterozygous for MC4R Mutations
Year: 2010
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Heterozygous mutations in melanocortin-4 receptor (MC4R) are the most frequent genetic cause of obesity. Bariatric surgery is a successful treatment for severe obesity. The mechanisms of weight loss after bariatric surgery are not well understood. METHODS: Ninety-two patients who had Roux-en-Y gastric bypass (RYGB) surgery were screened for MC4R mutations. We compared percent excess weight loss (%EWL) in the four MC4R mutation carriers with that of two control groups: 8 matched controls and with the remaining 80 patients who underwent RYGB. RESULTS: Four patients were heterozygous for functionally significant MC4R mutations. In patients with MC4R mutations, the %EWL after RYGB (66% EWL) was not significantly different compared to matched controls (70% EWL) and non-matched controls (60% EWL) after 1 year of follow-up. CONCLUSIONS: This study suggests that patients with heterozygous MC4R mutations also benefit from RYGB and that weight loss may be independent of the presence of such mutations.
Source: Obesity Surgery
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: Roux-en-Y gastric bypass, MC4R mutations
Open Access status: hybrid
Estimated APC paid: $4,590
Awards: The Melanocortin-4 Receptor in Human Obesity, Clinical and Translational Science Institute, Role of Pro-opiomelanocortin mutations in human obesity, Clinical and Transtional Science Institute, G6151251162, The Melanocortin-4 Receptor in Human Obesity, Training Program in Pediatric Endocrinology, Diabetes, Endocrinology & Metabolism Training Grant
OpenAlex ID: W2018315045
